Cargando…

Herceptin-sensitivity of HER2-transgenic mouse mammary tumors

Detalles Bibliográficos
Autores principales:	Schwall, RH, Hollingshead, P, Erickson, S, Winer, J, Williams, M, Dugger, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300134/ http://dx.doi.org/10.1186/bcr673

Ejemplares similares

Transgenic models are predictive: the herceptin and flavopiridol experience
por: Schmidt, E
Publicado: (2003)

Herceptin in clinical use - early 2000
por: Vogel, CL
Publicado: (2000)

Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results
por: Slamon, DJ
Publicado: (2000)

Estrogen receptor alpha-positive and negative mouse mammary tumors through somatic mutations of p53 in mammary carcinogenesis
por: Lin, S-CJ, et al.
Publicado: (2003)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

Mammary pathology of the genetically engineered mouse
por: Borowsky, AD
Publicado: (2003)

Targeting HER2 in breast cancer: beyond trastuzumab
por: Winer, EP
Publicado: (2011)

The mouse in preclinical trials: transgenic, carcinogen-induced, or xenograph models – which to use?
por: Brown, P
Publicado: (2003)

Reversibility and progression in conditional transgenic mouse models of breast cancer
por: Chodosh, LA, et al.
Publicado: (2003)

Expression of aquaporins in a transgenic mouse model of Alzheimer's disease
por: Chan, Sic L, et al.
Publicado: (2010)

Presence of HER4 associates with increased sensitivity to Herceptin™ in patients with metastatic breast cancer
por: Sassen, Andrea, et al.
Publicado: (2009)

Development of a transgenic mouse line for the evaluation of the androgen receptor activity in vivo
por: Attar, R, et al.
Publicado: (2003)

Serological Her2/neu-determination in patients receiving Herceptin(®)
por: Thomas, A, et al.
Publicado: (2001)

Integrin-mediated signal transduction in transgenic mouse models of human breast cancer
por: White, DE, et al.
Publicado: (2003)

Genetic manipulation of the mammary gland by transplantation
por: Edwards, P
Publicado: (2003)

Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?
por: Murphy, ML, et al.
Publicado: (2006)

Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?
por: Murphy, ML, et al.
Publicado: (2008)

Assessing ectomycorrhizal associations and transgene expression in transgenic Castanea dentata
por: D'Amico, Katherine, et al.
Publicado: (2011)

Regulation of human mammary stem cells
por: Clarke, RB, et al.
Publicado: (2003)

The molecular biology of mammary intraepithelial neoplasia outgrowths
por: Namba, L, et al.
Publicado: (2003)

Hormonal interactions during mammary gland development
por: Vonderhaar, BK
Publicado: (2003)

Function of LEF1 in early mammary development
por: Kratochwil, K, et al.
Publicado: (2003)

Evaluation of interleukins 8 and 12, CA 15-3 and free circulating DNA as prognostic markers in dogs with mammary tumors
por: Gelaleti, Gabriela B, et al.
Publicado: (2013)

Upregulation of ADAM proteases and HER ligands through a feedback loop mediates acquired resistance to trastuzumab in HER2-amplified breast cancer
por: Gijsen, M, et al.
Publicado: (2010)

Update on HER2-directed therapy
por: Slamon, D
Publicado: (2005)

Estrogen receptors α and β in the rodent mammary gland
por: Saji, S, et al.
Publicado: (2000)

Stromal and epithelial TGF-β signaling in mammary tumorigenesis
por: Moses, HL, et al.
Publicado: (2005)

Plant-Made Trastuzumab (Herceptin) Inhibits HER2/Neu+ Cell Proliferation and Retards Tumor Growth
por: Komarova, Tatiana V., et al.
Publicado: (2011)

Transgenic livestock for agriculture and biomedical applications
por: Long, Charles
Publicado: (2014)

Impact of pleural integrity during mammary artery harvesting on short term outcome
por: Pano, M, et al.
Publicado: (2013)

Update on HER-2 as a target for cancer therapy: Herceptin in the clinical setting
por: Miles, David W
Publicado: (2001)

Role of HER2 in local relapse and metastasis
por: Ménard, S
Publicado: (2005)

Genetic determinants of susceptibility to estrogen-induced mammary cancer in the rat
por: Shull, JD, et al.
Publicado: (2003)

Functional characterization of mammary stem cells in development and breast cancer
por: Rosen, JM, et al.
Publicado: (2003)

Delineation of anthracyclines and herceptin induced cardiotoxicity using contrast enhanced CMR
por: Hamirani, Yasmin S, et al.
Publicado: (2014)

Molecular mechanisms of resistance to HER2-targeted therapy
por: Esteva, FJ
Publicado: (2009)

Transforming growth factor β's role in mammary gland development and carcinogenesis
por: Barcellos-Hoff, MH
Publicado: (2003)

Combatting renal ciliopathies
por: Giles, RH
Publicado: (2012)

Insulin-like growth factor regulation of mammary gland development and tumorigenesis
por: Lee, AV
Publicado: (2005)

Mammary intraepithelial neoplasia outgrowths (MINO): MINO and human ductal carcinoma in situ
por: Borowsky, AD
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_jd22dnkujv3h118n739f2vsf1r